Companies Cryptocurrencies
10X Genomics Inc
10X Genomics Inc
Exchange: NasdaqGS
IPO Date: 12/09/2019
CEO: Mr. Serge Saxonov
Health Information Services Healthcare đź”—
  • TXG
  • 48.24
  • 5495211520
    market cap
  • -0.07999802
If you bought

shares of 10X Genomics Inc (TXG) on
You would have made
Old Price $12 Current Price $12

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. The company is headquartered in Pleasanton, California and currently employs 557 full-time employees. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company’s product consists of chromium single cell gene expression solution, cell immune profiling solution, cell copy number variation (CNV) solution, Cell assay for transposase accessible chromatin (ATAC) solution. The Company’s Chromium platform enables analysis of individual biological components, such as up to millions of single cells. Its Visium platform is designed to identify where biological components are located and how they are arranged with respect to each other. Its molecular assays are used with its Chromium platform, and with its planned Visium platform, to provide sensitive and robust biochemistries that convert minute amounts of biological analytes into detectable signals.

Address: 6230 Stoneridge Mall Road Pleasanton CALIFORNIA 94588

Stay updated.